ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2509

Implementation of the Treat to Target Concept in Evaluation of Rheumatoid Arthritis Patients

Devy Zisman1,2, Shirly Oren3, T. Reitblat4, Merav Lidar5, Alexandra Balbir-Gurman6, Itzhak A. Rosner7, Joy Feld2, Nimer Halabi8, Sameer Kassem8 and Ori Elkayam9, 1Technion, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel, 2Rheumatology Unit, Carmel Medical Center, Haifa, Israel, 3Rheumatology Unit, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel, 4Barzilai Medical Center, Ashkelon, Israel, 5Medicine F, Sheba Medical Center, Ramat Gan, Israel, 6B Shine Department of Rheumatology, Rambam Health Care Campus,. Rappaport Faculty of Medicine, Technion, Haifa, Israel, 7Bnai Zion Medical Center, Haifa, Israel, 8Internal Medicine, Carmel Medical Center, Haifa, Israel, 9Rheumatology, Tel Aviv Medical Center, Tel Aviv, Israel

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Rheumatoid arthritis (RA), treatment and treatment guidlelines

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess the implementation of the treat to target (T2T) concept in rheumatoid arthritis (RA) patients.

Methods: Academic rheumatology units were invited to participate in a retrospective study evaluating the implementation of the T2T concept in RA patients. The charts of consecutive RA patients attending the centers during June 2015, with 3 or more previous visits, were evaluated using a common questionnaire. Data collected included demographic parameters, alcohol consumption, smoking, concomitant diseases, age at RA onset, and the presence of rheumatoid factor (RF) and erosions. Validated disease activity scores [Disease Activity Score (DAS-28), Clinical Disease Activity Index (CDAI), Simple Disease Activity Index (SDAI), Routine Assessment of Patient Index Data (RAPID3)], RA treatment including conventional or biological DMARDS, drug dosages, side effects, and patients’ preferences were recorded. Two independent rheumatologists evaluated the data to assess the implementation of T2T concept. Statistical analysis: The associations between T2T concept implementation and categorical and continuous variables were assessed by Chi square test, t-test or Mann-Whitney test as appropriate. ANOVA or Kruskal-Wallis test was used to compare continuous variables between centers as appropriate.

Results: The seven participating centers reported 724 patients; age 62.6±13.97 years, 575 (80.4%) of them women. According to the reported data, 353 (65.4%) never smoked, 474 (73.3%) were married, 592 (86.8%) lived in cities, 191 (45.7%) had above high school education, 524 (72.4%) had comorbidities, 399 (66.4%) were RF positive and 125 (59.8%) had erosions. Four centers used more than one scoring method, DAS-28 and CDAI being the most popular. Only 276 (38.1%) of the patients had disease score results in ≥3 visits. The T2T approach was implemented in 245 (33.8%) of the 724 patients. The rate of implementation varied between centers (11.1%-87% p<0.0001), and was higher in younger patients (p=0.028), non-Jews (p=0.048), alcohol consuming (p=0.009) and RF positive patients (p=0.011). There was no correlation between the T2T implementation and gender, place of residence, education, smoking, treatment regimens, and the presence of erosions or comorbidities.

Conclusion: In our sample, the implementation of the T2T concept was limited. Further studies are needed to determine the reasons for this deviation from this desirable standard as well as its consequences.


Disclosure: D. Zisman, None; S. Oren, None; T. Reitblat, None; M. Lidar, None; A. Balbir-Gurman, None; I. A. Rosner, None; J. Feld, None; N. Halabi, None; S. Kassem, None; O. Elkayam, None.

To cite this abstract in AMA style:

Zisman D, Oren S, Reitblat T, Lidar M, Balbir-Gurman A, Rosner IA, Feld J, Halabi N, Kassem S, Elkayam O. Implementation of the Treat to Target Concept in Evaluation of Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/implementation-of-the-treat-to-target-concept-in-evaluation-of-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-the-treat-to-target-concept-in-evaluation-of-rheumatoid-arthritis-patients/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology